Michaël Abécassis

37.6k citations
333 papers · 23.8k · 7 hit papers · h-index 74

Impact in

  • Hepatology top 0.01%
    • Hepatocellular Carcinoma Treatment and Prognosis
    • Liver Disease and Transplantation
  • Transplantation top 0.05%
    • Renal Transplantation Outcomes and Treatments

Papers in

    • Organ Transplantation Techniques and Outcomes 120
    • Cholangiocarcinoma and Gallbladder Cancer Studies 21
    • Liver Disease and Transplantation 87
    • Hepatocellular Carcinoma Treatment and Prognosis 45

Michaël Abécassis

319 papers receiving 23.4k citations

Hit Papers

Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases 2019 · 516 citations
5160+6+12Years since publication10002.0k3.0k

Peers

Michaël Abécassis
Comparison fields: 5 of 172
  • Hepatology 15.5k
  • Transplantation 3.4k
  • Epidemiology 8.3k
  • Surgery 10.2k
  • Cancer Research 1.6k
Replace Pierre–Alain Clavien with:
Pierre–Alain Clavien Switzerland
P. Neuhaus Germany
Wolf O. Bechstein Germany
John P. Roberts United States
Henri Bismuth France
Robert S. Brown United States
Daniel Azoulay France
James Neuberger United Kingdom
Thomas E. Starzl United States
David Grant Canada
Michaël Abécassis relative to Pierre–Alain Clavien Switzerland Pierre–Alain Clavien's profile →
Citations per field
00.5×2.9×
Pierre–Alain Clavien · 1×
Citations per year

Countries citing papers authored by Michaël Abécassis

Since Specialization
Citations

This map shows the geographic impact of Michaël Abécassis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michaël Abécassis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michaël Abécassis more than expected).

Fields of papers citing papers by Michaël Abécassis

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michaël Abécassis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michaël Abécassis. The network helps show where Michaël Abécassis may publish in the future.

Co-authors

The 25 scholars most cited alongside Michaël Abécassis, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Michaël Abécassis Line = papers co-authored together Michaël Abécassis links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 333 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Hit paper breakdown →
20183150
2
AASLD guidelines for the treatment of hepatocellular carcinoma
Hit paper breakdown →
20172919
3
Validation of a current definition of early allograft dysfunction in liver transplant recipients and analysis of risk factors
Hit paper breakdown →
2010835
4
Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes
Hit paper breakdown →
2009740
5
Diagnosis, Staging, and Management of Hepatocellular Carcinoma: 2018 Practice Guidance by the American Association for the Study of Liver Diseases
Hit paper breakdown →
2019516
6
Y90 Radioembolization Significantly Prolongs Time to Progression Compared With Chemoembolization in Patients With Hepatocellular Carcinoma
Hit paper breakdown →
2016433
7 2007430
8
Kidney Transplantation as Primary Therapy for End-Stage Renal Disease
Hit paper breakdown →
2008430
9 2009422
10 2007376
11 2012326
12 2005263
13 2012252
14 2009249
15 2006244
16 2011241
17 2014227
18 1989218
19 2013196
20 2008194

About Michaël Abécassis

Michaël Abécassis is a scholar working on Surgery, Hepatology, Transplantation, Epidemiology and Public Health, Environmental and Occupational Health, having authored 333 papers that have together received 23.8k indexed citations. Recurring topics across this work include Organ Transplantation Techniques and Outcomes (120 papers), Renal Transplantation Outcomes and Treatments (107 papers), Liver Disease and Transplantation (87 papers), Liver Disease Diagnosis and Treatment (47 papers), Hepatocellular Carcinoma Treatment and Prognosis (45 papers), Organ Donation and Transplantation (43 papers), Cytomegalovirus and herpesvirus research (34 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (21 papers). The work is most often cited by research in Hepatology (15.5k citations), Transplantation (3.4k citations), Epidemiology (8.3k citations), Surgery (10.2k citations) and Cancer Research (1.6k citations). Michaël Abécassis has collaborated with scholars based in United States, United Kingdom and Canada. Frequent co-authors include Laura Kulik, Julie K. Heimbach, Claude B. Sirlin, Andrew X. Zhu, Richard S. Finn, Jorge A. Marrero, Lewis R. Roberts, Talia Baker, Riad Salem and Robert J. Lewandowski. Their work appears in journals such as Transplantation, American Journal of Transplantation, Liver Transplantation, Hepatology and Journal of Vascular and Interventional Radiology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact